Aetna, Cigna, and UnitedHealthcare: TMS and Spravato Coverage Explained
Quick Answer: Aetna, Cigna, and UnitedHealthcare all cover TMS and Spravato for treatment-resistant depression when medical necessity criteria are met. Coverage for TMS for OCD is more variable. Each carrier has its own prior authorization process, and the specific requirements (number of failed medication trials, documentation needed, ongoing therapy criteria) shift over time. At Elevium Health, the billing team runs benefits checks and handles prior authorization before treatment starts, so you'll know what's covered before anything is scheduled.
If you've filled out the contact form, the cost question is usually the next one on your mind. This post covers what to expect with the three carriers that come up most often — what's typically covered, what prior authorization involves, and how Elevium handles the back-and-forth so you don't have to.
A Quick Note Before the Carrier Breakdown
Two things to set expectations on:
Carrier policies change. What Aetna covered six months ago isn't necessarily what they cover today. Specific criteria - how many medication trials count as "failed," what documentation a prior authorization needs, and whether maintenance sessions are covered — get updated quarterly across all three carriers. Anything below is directional. We confirm specifics with your plan at the benefits check.
"In-network" and "covered" aren't the same thing. A treatment can be a covered benefit under your plan, but still requires prior authorization, and that authorization can be denied if the criteria aren't met. Coverage is the door; prior auth is the key.
TMS Coverage Across the Three Carriers
Aetna
Aetna covers TMS for treatment-resistant major depressive disorder. The typical pattern: you need a documented diagnosis of MDD, a history of failed antidepressant trials, and evidence that you're currently engaged in (or have tried) psychotherapy. Prior authorization is required before treatment starts. Aetna also has specific criteria for what counts as a "failed" trial — duration, dose, and adherence all matter.
For TMS for OCD, Aetna coverage is a more variable plan-to-plan and may require additional documentation. Worth checking specifically when we run benefits.
Cigna
Cigna's TMS coverage follows a similar treatment-resistant depression framework: documented MDD diagnosis, failed medication trials, and prior authorization. Cigna has been one of the more straightforward carriers for adult TMS approvals when the criteria are clearly documented.
For TMS for OCD, Cigna coverage exists but tends to require stronger documentation of symptom severity and prior treatment history.
UnitedHealthcare
UnitedHealthcare covers TMS for treatment-resistant depression under similar criteria — documented diagnosis, failed antidepressant trials, prior authorization. UHC plans vary significantly between commercial, Optum-administered, and employer-specific variants, so coverage and the prior auth pathway can look different depending on which UHC plan you have.
For TMS for OCD, UHC coverage varies meaningfully across plans. Some cover it under the same criteria as TMS for depression; others require additional review.
Spravato Coverage Across the Three Carriers
Spravato (esketamine) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation. All three carriers cover it, but the prior authorization bar is generally higher than for TMS.
Common requirements across Aetna, Cigna, and UHC:
- Documented MDD diagnosis
- Failed trials of at least two antidepressants from different classes
- Concurrent oral antidepressant during Spravato treatment (this is FDA-required, not just an insurance requirement)
- Treatment delivered at a REMS-certified facility (Elevium is certified)
- Adherence to the FDA-mandated post-dose monitoring period
The carriers diverge on:
- How many medication trials count toward the "failed" requirement
- Whether they require evidence of psychotherapy alongside medication trials
- How they handle continuation of treatment after the initial induction phase
- Ketamine therapy — distinct from Spravato — is generally not covered by any of the three. It's considered off-label for depression by most plans. If insurance approval is critical, Spravato is usually the better-covered esketamine option.
What Prior Authorization Actually Involves
Prior authorization (PA) is the carrier's review of whether your treatment meets their medical necessity criteria. The general flow:
1. Benefits check. We confirm what your plan covers and what your costs would be — copay, coinsurance, and deductible. Free, takes 1–3 business days depending on the carrier.
2. PA submission. If treatment is a covered benefit, we submit the prior authorization request with supporting documentation: diagnosis, medication trial history, current symptoms, and treatment plan.
3. Carrier review. Decision usually within 5–14 business days. Standard reviews take longer than urgent ones; we flag urgency when clinically warranted.
4. Approval or denial. Approval comes with many sessions authorized and a date range. Denials come with a reason — usually fixable through additional documentation, an updated medication history, or a peer-to-peer review where Dr. Krishnappa or Dr. Rajagopal speaks directly with the carrier's medical reviewer.
5. Re-authorization. Some treatment courses require re-auth partway through. We handle that too.
Most denials we see are fixable. The most common reasons — insufficient documentation of medication trials, missing therapy engagement evidence, or unclear treatment-resistance criteria — can usually be addressed with a stronger submission or a peer-to-peer call.
How Elevium Handles This for You
The billing team runs every part of this in-house:
- Benefits check before you commit to anything
- Prior authorization submission with all clinical documentation
- Peer-to-peer reviews when needed (Dr. Krishnappa or Dr. Rajagopal speaks directly with the carrier)
- Re-authorizations during longer treatment courses
- Appeals if a denial isn't justified
You get the result. We do the chasing.
What if my plan isn't Aetna, Cigna, or UnitedHealthcare?
We work with most major carriers, including Horizon Blue Cross Blue Shield of New Jersey and several others. The benefits check process is the same. Call or fill out the contact form with your insurance details and we'll confirm.
What if I'm denied?
Denials are usually fixable through appeal, additional documentation, or a peer-to-peer review with the carrier's medical reviewer. We don't charge extra for handling appeals — it's part of the standard process.
Do I have to pay anything before insurance approval comes through?
No. We don't start treatment until prior authorization is in place. The benefits check is free.
Can I self-pay if insurance doesn't approve?
Yes. Self-pay rates are available for TMS and Spravato. We'll go through the rates and any financing options during the consultation.
How long does the whole insurance process take?
From first contact to treatment start: typically two to four weeks, depending on how quickly the carrier processes the prior auth and how complete your medication history documentation is. Bringing detailed records to the consultation shortens the timeline.
Share Article



















